封面
市場調查報告書
商品編碼
1672870

按疫苗類型、適應症、給藥途徑和地區分類的魚疫苗市場

Fish Vaccine Market, By Vaccine Type, By Indication, By Route of Administration, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 177 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球魚疫苗市場規模估計為 4.1 億美元,預計到 2032 年將達到 7.646 億美元,2025 年至 2032 年的複合年成長率為 9.3%。

報告範圍 報告詳細資訊
基準年 2024 2025 年市場規模 4.1億美元
效能資料 2020-2024 預測期 2025-2032
預測期:2025 年至 2032 年複合年成長率 9.30% 2032 年金額預測 7.646億美元
數字。 2025 年魚類疫苗市場佔有率(按地區)
魚疫苗市場-IMG1

由於水產養殖業的興起和致命魚類疾病的日益流行,全球魚類疫苗市場在過去幾年中一直保持穩定成長。魚類疫苗有助於保護魚類族群免受感染疾病,並避免對養魚者和貿易業者帶來重大經濟損失。該疫苗有助於為水產養殖中飼養的用於食用和觀賞目的的魚類接種疫苗。魚貝類消費量的增加,以及對永續養魚需求的不斷成長,可能會在不久的將來導致全球對魚類疫苗的需求增加。

市場動態

由於全球魚貝類的需求不斷增加,水產養殖實踐的採用不斷增加,可能會推動魚類疫苗市場的成長。各種病毒和細菌感染(如弧菌病和上皮囊蟲病)在養殖鮭魚中日益流行,尤其是在歐洲和北美,這可能會促進魚類疫苗的銷售。然而,魚疫苗研發的高成本以及新型魚疫苗上市的嚴格規定可能會阻礙市場的成長。同時,採用新型佐劑技術開發高效的耐熱魚疫苗可能為工業製造商提供有利可圖的機會。

研究的主要特點

  • 本報告對全球魚疫苗市場進行了詳細分析,並提供了預測期(2025-2032)的市場規模和年複合成長率(CAGR%),假設 2024 年為基準年。
  • 它揭示了不同領域的潛在商機並解釋了該市場的有吸引力的投資提案矩陣。
  • 它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
  • 全球魚疫苗市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數進行的分析。
  • 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球魚疫苗市場報告迎合了該行業的各個相關人員,例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
  • 相關人員可以透過分析全球魚類疫苗市場所使用的各種策略矩陣來促進他們的決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • 一致的機會圖 (COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 影響分析
  • 市場趨勢
  • 監管情景
  • 收購和合作場景
  • 資金籌措和投資
  • PEST分析
  • 波特的分析

4. 全球魚類疫苗市場 - 冠狀病毒 (COVID-19) 大流行的影響

  • 整體影響
  • 政府舉措
  • COVID-19 市場影響

5. 2020-2032 年全球魚類疫苗市場(按疫苗類型分類)(百萬美元)

  • 介紹
  • 去活化疫苗
  • 去活化疫苗
  • 減毒疫苗
  • 類毒素疫苗
  • 次單位疫苗
  • 結合疫苗
  • 重組載體疫苗

6. 全球魚類疫苗市場,依適應症,2020-2032 年(百萬美元)

  • 介紹
  • 癤病
  • 弧菌病
  • 鼠疫桿菌
  • 腸膿毒症
  • 其他

7. 2020-2032 年全球魚類疫苗市場(依給藥途徑分類)(百萬美元)

  • 介紹
  • 注射
  • 浸沒
  • 口服

8. 2020-2032 年全球魚類疫苗市場(按地區分類)(百萬美元)

  • 介紹
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第9章 競爭格局

  • 公司簡介
    • Merck Animal Health(MSD Animal Health)
    • Zoetis
    • Elanco
    • Virbac
    • HIPRA
    • Veterquimica SA
    • Tecnovax
    • Phibro Animal Health Corporation
    • Ridgeway Biologicals Ltd.
    • Nisseiken Co., Ltd.
    • Aquatic Animal Health Ltd
    • Ictyogroup
    • Benchmark Holdings plc
    • Vaxxinova
    • Alpha BIoTech Ltd.
    • Vallee SA
    • Ringpu Biology
    • Nippon Zenyaku Kogyo Co., Ltd.
    • Chengdu Tech-bank Biological Products
    • Weiyuan Gene Tech

第 10 章分析師建議

  • 興衰
  • 一致的機會地圖

第 11 章 參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI5184

Global Fish Vaccine Market is estimated to be valued at USD 410.0 Mn in 2025 and is expected to reach USD 764.6 Mn by 2032, growing at a compound annual growth rate (CAGR) of 9.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 410.0 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 9.30% 2032 Value Projection: USD 764.6 Mn
Figure. Fish Vaccine Market Share (%), By Region 2025
Fish Vaccine Market - IMG1

Global fish vaccine market has witnessed steady growth in the past few years, owing to rise in aquaculture industry and increasing prevalence of deadly fish diseases. Fish vaccines help prevent fish populations from infectious diseases, thus, avoiding heavy economic losses to fish farmers and traders. Vaccines aid immunization of fish species that are raised through aquaculture practices for both food and ornamental purposes. Growing consumption of seafood along with rising demand for sustainable fish farming can boost demand for fish vaccines globally in the near future.

Market Dynamics:

Increasing adoption of aquaculture practices due to rising global seafood demand can drive the fish vaccine market growth. Increasing prevalence of various viral and bacterial infections such as Vibriosis and Epitheliocystis disease particularly among salmon species farmed in Europe and North America can boost sales of fish vaccines. However, high costs associated with fish vaccine R&D and stringent regulations pertaining to launch of new fish vaccines can hamper the market growth. Meanwhile, introduction of novel adjuvant technologies for developing efficient thermostable fish vaccines can provide lucrative business opportunities for manufacturers in the industry.

Key Features of the Study:

  • This report provides in-depth analysis of the global fish vaccine market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global fish vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Zoetis, Merck & Co., Inc., Phibro Animal Health Corporation, Virbac, Hipra, Veterquimica S.A., Tecnovax, Anthropic, HIPRA
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global fish vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fish vaccine market

Detailed Segmentation-

  • By Vaccine Type:
    • Killed Vaccine
    • Inactivated Vaccine
    • Attenuated Vaccine
    • Toxoid Vaccine
    • Subunit Vaccine
    • Conjugate Vaccine
    • Recombinant Vector Vaccines
  • By Indication:
    • Furunculosis
    • Vibriosis
    • Yersiniosis
    • Enteric septicaemia
    • Others
  • By Route of Administration:
    • Injection
    • Immersion
    • Spray
    • Oral
  • Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Merck Animal Health (MSD Animal Health)
    • Zoetis
    • Elanco
    • Virbac
    • HIPRA
    • Veterquimica S.A.
    • Tecnovax
    • Phibro Animal Health Corporation
    • Ridgeway Biologicals Ltd.
    • Nisseiken Co., Ltd.
    • Aquatic Animal Health Ltd
    • Ictyogroup
    • Benchmark Holdings plc
    • Vaxxinova
    • Alpha Biotech Ltd.
    • Vallee S.A.
    • Ringpu Biology
    • Nippon Zenyaku Kogyo Co., Ltd.
    • Chengdu Tech-bank Biological Products
    • Weiyuan Gene Tech

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Vaccine Type
    • Market Snapshot, By Indication
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Fish Vaccine Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Fish Vaccine Market, By Vaccine Type, 2020 - 2032, (USD Mn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Killed Vaccine
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Inactivated Vaccine
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Attenuated Vaccine
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Toxoid Vaccine
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Subunit Vaccine
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Conjugate Vaccine
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Recombinant Vector Vaccines
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Fish Vaccine Market, By Indication, 2020 - 2032, (USD Mn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Furunculosis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Vibriosis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Yersiniosis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Enteric septicaemia
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Fish Vaccine Market, By Route of Administration, 2020 - 2032, (USD Mn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Injection
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Immersion
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Spray
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Oral
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Fish Vaccine Market, By Region, 2020 - 2032, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Mn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Merck Animal Health (MSD Animal Health)
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Zoetis
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Elanco
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Virbac
    • HIPRA
    • Veterquimica S.A.
    • Tecnovax
    • Phibro Animal Health Corporation
    • Ridgeway Biologicals Ltd.
    • Nisseiken Co., Ltd.
    • Aquatic Animal Health Ltd
    • Ictyogroup
    • Benchmark Holdings plc
    • Vaxxinova
    • Alpha Biotech Ltd.
    • Vallee S.A.
    • Ringpu Biology
    • Nippon Zenyaku Kogyo Co., Ltd.
    • Chengdu Tech-bank Biological Products
    • Weiyuan Gene Tech

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About Us and Sales Contact